Fibrocystic breast disease

Fibrocystic breast disease, more commonly termed fibrocystic breast changes, is a benign condition characterized by cyclical breast pain, tenderness, and diffuse nodularity or lumpiness It predominantly affects females of reproductive age, particularly between 30 and 50 years, due to heightened sensitivity to cyclical ovarian hormones such as estrogen and progesterone

Fibrocystic breast disease, more commonly termed fibrocystic breast changes, is a benign condition characterized by cyclical breast pain, tenderness, and diffuse nodularity or lumpiness

Fibrocystic breast disease, more commonly termed fibrocystic breast changes, is a benign condition characterized by cyclical breast pain, tenderness, and diffuse nodularity or lumpiness

It predominantly affects females of reproductive age, particularly between 30 and 50 years, due to heightened sensitivity to cyclical ovarian hormones such as estrogen and progesterone Pathophysiologically, repeated hormonal stimulation and involution lead to stromal fibrosis, epithelial proliferation, and the formation of microscopic or macroscopic fluid-filled cysts within the terminal duct lobular units Clinical manifestations typically fluctuate across the menstrual cycle, frequently peaking...

It predominantly affects females of reproductive age, particularly between 30 and 50 years, due to heightened sensitivity to cyclical ovarian hormones such as estrogen and progesterone Clinical manifestations typically fluctuate across the menstrual cycle, frequently peaking during the premenstrual phase, and generally resolve or diminish following menopause